126 related articles for article (PubMed ID: 32253665)
1. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
Saburi M; Ogata M; Satou T; Soga Y; Itani K; Kohno K; Kondo Y; Nakayama T
Int J Hematol; 2020 Jul; 112(1):17-23. PubMed ID: 32253665
[TBL] [Abstract][Full Text] [Related]
2. Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia.
De Bellis E; Ottone T; Mercante L; Falconi G; Cugini E; Consalvo MI; Travaglini S; Paterno G; Piciocchi A; Rossi ELL; Gurnari C; Maurillo L; Buccisano F; Arcese W; Voso MT
Leuk Res; 2020 Dec; 99():106462. PubMed ID: 33091616
[TBL] [Abstract][Full Text] [Related]
3. TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation.
Patel KP; Khokhar FA; Muzzafar T; James You M; Bueso-Ramos CE; Ravandi F; Pierce S; Medeiros LJ
Mod Pathol; 2013 Feb; 26(2):195-203. PubMed ID: 22936064
[TBL] [Abstract][Full Text] [Related]
4. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
7. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
[TBL] [Abstract][Full Text] [Related]
8. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.
Foa R; Casorati G; Giubellino MC; Basso G; Schirò R; Pizzolo G; Lauria F; Lefranc MP; Rabbitts TH; Migone N
J Exp Med; 1987 Mar; 165(3):879-90. PubMed ID: 3102679
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
Zhang Y; Liu RY; Wang SJ; Wang C; Zhang QT; He C; Xie XS; Wan DM; Jiang ZX; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1880-1884. PubMed ID: 33283714
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.
Skoog L; Ost A; Biberfeld P; Christensson B; Hast R; Lagerlöf B; Nordenskjöld B; Reizenstein P
Br J Cancer; 1984 Oct; 50(4):443-9. PubMed ID: 6593093
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Paietta E; Racevskis J; Bennett JM; Wiernik PH
Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
[TBL] [Abstract][Full Text] [Related]
14. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
[TBL] [Abstract][Full Text] [Related]
15. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
[TBL] [Abstract][Full Text] [Related]
16. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
17. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
[TBL] [Abstract][Full Text] [Related]
20. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia.
Jani P; Verbi W; Greaves MF; Bevan D; Bollum F
Leuk Res; 1983; 7(1):17-29. PubMed ID: 6572772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
